YC S21
Yemaachi Biotechnology
Diversifying precision cancer diagnostics and treatments
About
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Founders
- Yaw Attua-Afari
- Joyce Ngoi
Family Office Investors
2 deals trackedAltss has tracked family office activity in Yemaachi Biotechnology. Investors shown are from our private markets database.
- Ethan Perlstein (Angel)
- Gagan Gupta (Angel)
Industry & Focus
HealthcareDiagnosticsBiotechTherapeutics